Optimizing the Floreciendo Sexual and Reproductive Health Workshop for Latina Teens and Female Caregivers: A Pilot
Launched by UNIVERSITY OF ILLINOIS AT CHICAGO · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a program called Floreciendo, which is designed to improve sexual and reproductive health for Latina teens aged 14 to 18 and their female caregivers, like mothers or grandmothers. The goal is to see how effective and acceptable this workshop is in helping participants learn about sexual health, reduce risky behaviors, and prevent issues like sexually transmitted infections and unplanned pregnancies. The study will take place in community organizations in the Chicago area and will use a method that allows researchers to test different parts of the program to find out what works best.
To participate, Latina teens must be between 14 and 18 years old, speak English or Spanish, and be living with or have daily contact with a female caregiver who is also willing to join the workshop. The caregiver must be at least 19 years old. Both the teen and caregiver should agree to take part together, and the study will respect their privacy regarding sensitive topics. Participants can expect to engage in workshops that are informative and supportive, and they can continue in the study even if personal circumstances change, like becoming pregnant.
Gender
ALL
Eligibility criteria
- Inclusion criteria for teens:
- • 1. Identify as Latina
- • 2. Be 14-18 years old
- • 3. Speak English and/or Spanish
- • 4. Be available and have a female caregiver who is available for the workshop and research activities.
- • 5. Be living with or in daily contact with the female caregiver.
- Inclusion criteria for female caregivers:
- • 1. Be the mother or a female caregiver (e.g., aunt, sister, grandmother) of a Latina teen (aged 14-18 years old)
- • 2. Be 19 years old or older
- • 3. Speak English and/or Spanish
- • 4. Be available and have a teen who is available for the workshop and research activities.
- • 5. Be living with or in daily contact with the Latina teen.
- • Latina teens and female caregivers must agree to participate as a dyad, and teens' refusal will supersede parental consent.
- Exclusion Criteria:
- • Teens and caregivers will be excluded if they are unable to understand the consent/assent process and provide informed consent/assent or if they already received the intervention in a previous phase of the research. Teens may or may not be sexually active; this will not be an exclusion criterium. Information about teens' sexual activity will not be shared with caregivers to reduce consent/assent barriers. If there is more than one eligible adolescent in the family, we will randomly select one to maintain independent observations. Teens or caregivers who become pregnant during the study may continue to participate. Prisoners will be excluded.
About University Of Illinois At Chicago
The University of Illinois at Chicago (UIC) is a leading academic institution renowned for its commitment to advancing health sciences through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, UIC harnesses the expertise of its diverse faculty and state-of-the-art facilities to conduct cutting-edge clinical studies aimed at improving patient outcomes. The university's robust infrastructure for clinical research, combined with its dedication to ethical standards and regulatory compliance, positions UIC as a pivotal contributor to the development of new treatments and therapies in various medical fields. Through strategic partnerships and community engagement, UIC strives to translate research findings into real-world applications, enhancing the health and well-being of populations locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Chicago, Illinois, United States
Cicero, Illinois, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported